Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ NDC 18657-117-04
Published December 18, 2024 · Recall initiated: September 11, 2024
Summary
FDA records drug Class II recall D-0116-2025, published December 18, 2024 and initiated September 11, 2024. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Terminated; Reported quantity: 5 cartons/20 units each carton; Lot: Serial # 100000831961 100000820688 100000820689 100000820515. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations: Temperature excursion
What to do
Voluntary: Firm initiated · Letter
Get an email if HYLENEX RECOMBINANT has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HYLENEX RECOMBINANT
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Distributor
- Virgina
- Lot
- Serial # 100000831961 100000820688 100000820689 100000820515
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAKirkland Severe Cold & Flu Plus Congestion: Day - 112 coated caplets blister pack; (Acetaminophen 325mg,December 18, 2024
- FDAJavygtor (sapropterin dihydrochloride) Tablets 100mg, 120-count bottle, Rx Only, Distributor: Dr. Reddy'sDecember 18, 2024
- FDATimolol Maleate Ophthalmic Solution USP, 0.25%, Sterile, 15mL bottles, Rx only, Manufactured by: FDC Limited,December 18, 2024
- FDALevothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b)December 18, 2024
- FDAVarithena (polidocanol injectable foam) Administration Pack, Contains: 3 silicone-free syringes, 2 compressionDecember 18, 2024
- FDALevothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823-77) and b)December 18, 2024
Questions about this recall
Was Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ NDC 18657-117-04 recalled?
Yes. FDA published recall D-0116-2025 on December 18, 2024. Reported hazard: cGMP Deviations: Temperature excursion
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HYLENEX RECOMBINANT.